Investors

Person

Last mentioned: 3d ago

Timeline

Invalid Date
Lead Counsel Appointment

Expected timeframe for the court to designate the lead plaintiff and legal representation.
May 11, 2026
Lead Plaintiff Deadline

Final day for affected investors to petition the court to lead the class action.
Mar 12, 2026
Lawsuit Announcements

Schall Law Firm files class action notices for Soleno Therapeutics and Ultragenyx Pharmaceutical.

Stories mentioning Investors 1

Schall Law Firm Targets Soleno and Ultragenyx in Dual Securities Fraud Actions

The Schall Law Firm has initiated securities fraud class actions against Soleno Therapeutics and Ultragenyx Pharmaceutical, alleging violations of federal securities laws. The firm is currently seeking lead plaintiffs to represent the class in these high-stakes biotech litigations following potential misrepresentations to the market.

3d ago 2 sources